Reduced-Dose Chemotherapy Followed By Blinatumomab As Induction Therapy in Treatment of Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia - Interim Results from a Multicenter, Single-Arm, Phase 2 Study

被引：0
|
作者：
Lu, Jing [1 ]
Wang, Ying [2 ]
Qiu, Huiying [3 ]
Zhou, Xin [4 ]
Lu, Xuzhang [5 ]
Miao, Miao [6 ]
Gu, Bin [1 ]
Hu, Xiaohui [1 ]
Wu, Depei [6 ]
Chen, Suning [1 ]
机构：
[1] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Natl Clin Res Ctr Hematol Dis,Dept Hematol, Suzhou, Peoples R China
[2] Soochow Univ, Affiliated Hosp 1, Natl Clin Res Ctr Hematol Dis, Jiangsu Inst Hematol, Suzhou, Peoples R China
[3] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol,Natl Clin Res Ctr Hematol Di, Dept Hematol,Collaborat Innovat Ctr Hematol, Suzhou, Peoples R China
[4] Nanjing Med Univ, Wuxi Peoples Hosp, Dept Hematol, Wuxi, Jiangsu, Peoples R China
[5] Nanjing Med Univ, Affiliated Changzhou Hosp 2, Dept Hematol, Changzhou, Jiangsu, Peoples R China
[6] Soochow Univ, Affiliated Hosp 1, Suzhou, Peoples R China
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-174831
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Dose Reduced Chemotherapy in Sequence with Blinatumomab for Newly Diagnosed Older Patients with Ph/BCR::ABL Negative B-Precursor Adult Lymphoblastic Leukemia (ALL): Preliminary Results of the GMALL Bold Trial
    Goekbuget, Nicola
    Schwartz, Stefan
    Faul, Christoph
    Topp, Max S.
    Subklewe, Marion
    Renzelmann, Andrea
    Stoltefuss, Andrea
    Hertenstein, Bernd
    Wilke, Anne
    Raffel, Simon
    Jaekel, Nadja
    Vucinic, Vladan
    Niemann, Dirk Markus
    Reiser, Lena
    Serve, Hubert
    Brueggemann, Monika
    Viardot, Andreas
    BLOOD, 2023, 142
  • [42] Age Subgroup Analysis of Health-Related Quality of Life of Blinatumomab Versus Standard-of-Care Chemotherapy in Patients with Relapsed or Refractory Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia in a Randomized, Open-Label, Phase 3 Study (TOWER)
    Topp, Max S.
    Zimmerman, Zachary F.
    Cannell, Paul
    Dombret, Herve
    Maertens, Johan
    Stein, Anthony S.
    Franklin, Janet L.
    Cong, Ze
    Zhang, Xinke
    Schuh, Andre
    BLOOD, 2018, 132
  • [43] Venetoclax combined with daunorubicin and cytarabine (2+6) as induction treatment in adults with newly diagnosed acute myeloid leukemia: a phase 2, multicenter, single-arm trial
    Suo, Xiaohui
    Zheng, Fang
    Wang, Dongmei
    Zhao, Liyun
    Liu, Jie
    Li, Ling
    Zhang, Zhihua
    Zhang, Congcong
    Li, Yinling
    Yang, Sisi
    Zhao, Xuemei
    Shi, Rui
    Wu, Yan
    Jiao, Zongjiu
    Song, Jiaojie
    Zhang, Ling
    Lu, Xinxiao
    Yuan, Linyu
    Gao, Sifeng
    Zhang, Jilei
    Zhao, Xingli
    Bai, Guanchen
    Liu, Kaiqi
    Mi, Yingchang
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2023, 12 (01)
  • [44] A Phase I/II Study of Inotuzumab Ozogamicin in Combination with Low-Intensity Chemotherapy (mini-hyper-CVD) for Older Patients with Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia
    Short, Nicholas J.
    Kantarjian, Hagop M.
    Ravandi, Farhad
    Huang, Xuelin
    Jain, Nitin
    Daver, Naval
    Thomas, Deborah A.
    Pemmaraju, Naveen
    Khouri, Rita
    Khoury, Joseph David
    Jorgensen, Jeffrey L.
    Alvarado, Yesid
    Sasaki, Koji
    Konopleva, Marina
    Garcia-Manero, Guillermo
    Kadia, Tapan
    Cortes, Jorge E.
    Benton, Christopher B.
    Borthakur, Gautam
    Burger, Jan A.
    Ohanian, Maro
    Wierda, William G.
    Estrov, Zeev
    Kornblau, Steven
    DiNardo, Courtney D.
    Ferrajoli, Alessandra
    Jacob, Jovitta
    Manzoor, Ameena
    Garris, Rebecca
    O'Brien, Susan M.
    Jabbour, Elias J.
    BLOOD, 2017, 130
  • [45] OPEN-LABEL, SINGLE-ARM, MULTICENTER CONFIRMATORY PHASE 2 STUDY OF THE BITE® ANTIBODY BLINATUMOMAB IN PATIENTS WITH RELAPSED/REFRACTORY B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKAEMIA
    Topp, M.
    Goekbuget, N.
    Stein, A. S.
    Bargou, R. C.
    Dombret, H.
    Fielding, A. K.
    Ribera, J. M.
    Foa, R.
    Zugmaier, G.
    Holland, C.
    Maniar, T.
    Huber, B.
    Nagorsen, D.
    Kantarjian, H. M.
    HAEMATOLOGICA, 2014, 99 : 258 - 258
  • [46] Updated results from a phase II study of mini-hyper-CVD (mini-HCVD) plus inotuzumab ozogamicin (INO), with or without blinatumomab (Blina), in older adults with newly diagnosed Philadelphia chromosome (Ph)-negative B-cell acute lymphoblastic leukemia (ALL).
    Macaron, Walid
    Kantarjian, Hagop M.
    Short, Nicholas James
    Ravandi, Farhad
    Jain, Nitin
    Kadia, Tapan M.
    Haddad, Fadi
    Valero, Yesid Alvarado
    Daver, Naval Guastad
    Borthakur, Gautam
    Dinardo, Courtney Denton
    Konopleva, Marina
    Wierda, William G.
    Jacob, Jovitta
    Roy, Edith
    Loiselle, Christopher
    Milton, Anna
    Rivera, Juan
    Garris, Rebecca
    Jabbour, Elias
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [47] Blinatumomab Alternating With Low-Intensity Chemotherapy (CT) Treatment for Older Adults With Newly Diagnosed Philadelphia (Ph)-Negative B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) is Well Tolerated and Efficacious: Safety Run-In Results for the Phase 3 Randomized Controlled Golden Gate Study
    Jabbour, Elias
    Aldoss, Ibrahim
    Fleming, Shaun
    Bajel, Ashish
    Cannell, Paul
    Bruggemann, Monika
    Zugmaier, Gerhard
    Morris, Joan
    Chen, Yuqi
    Powar, Sonny
    Wong, Hansen
    Steffen, Bjorn
    Kantarjian, Hagop
    Goekbuget, Nicola
    BLOOD, 2022, 140 : 6134 - 6136
  • [48] Phase 2 Trial of Mini-Hyper-CVD Plus Inotuzumab Ozogamicin, with or without Blinatumomab, in Older Patients with Newly Diagnosed Philadelphia ChromosomeNegative B-Cell Acute Lymphoblastic Leukemia
    Jen, lWei-Ying
    Jabbour, Elias
    Haddad, Fadi G.
    Short, Nicholas J.
    Jain, Nitin
    Kadia, Tapan M.
    Daver, Naval
    Borthakur, Gautam
    Nasr, Lewis
    DiNardo, Courtney D.
    Zoghbi, Marianne
    Jacob, Jovitta
    Roy, Edith
    Loiselle, Christopher
    Milton, Anna
    Rivera, Juan
    Garris, Rebecca
    Ravandi, Farhad
    Kantarjian, Hagop M.
    BLOOD, 2023, 142
  • [49] Mini-hyper-CVD plus inotuzumab ozogamicin (InO), with or without blinatumomab (Blina), in older patients with newly diagnosed Philadelphia chromosome (Ph)-negative B-cell acute lymphoblastic leukemia (ALL): Updates from a phase II trial
    Nasnas, Cedric Christophe
    Jabbour, Elias
    Haddad, Fadi
    Short, Nicholas James
    Nasr, Lewis Fady
    Macaron, Walid
    Zoghbi, Marianne
    Ravandi, Farhad
    Jain, Nitin
    Kadia, Tapan M.
    Daver, Naval Guastad
    Borthakur, Gautam
    Dinardo, Courtney Denton
    Jacob, Jovitta
    Roy, Edith
    Loiselle, Christopher
    Milton, Anna
    Rivera, Juan
    Garris, Rebecca
    Kantarjian, Hagop M.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [50] BLINATUMOMAB IMPROVED OVERALL SURVIVAL IN PATIENTS WITH RELAPSED OR REFRACTORY PHILADELPHIA NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA IN A RANDOMIZED, OPEN-LABEL PHASE 3 STUDY (TOWER)
    Topp, M. S.
    Stein, A.
    Goekbuget, N.
    Fielding, A.
    Schuh, A.
    Ribera Santasusana, J. M.
    Wei, A.
    Dombret, H.
    Foa, R.
    Bassan, R.
    Arslan, O.
    Sanz, M. A.
    Bergeron, J.
    Demirkan, F.
    Lech-Maranda, E.
    Rambaldi, A.
    Thomas, X.
    Fleishman, A.
    Nagorsen, D.
    Holland, C.
    Zimmerman, Z.
    Kantarjian, H.
    HAEMATOLOGICA, 2016, 101 : 24 - 25
12345